SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)
$25.16 0.74 (3.0303%)
Analysed SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) News Sources
SMMT Stock Up 24% in Three Months: Here's What You Need to Know
16-04-2026
yahoo.com
A Look At Summit Therapeutics (SMMT) Valuation After New Ivonescimab Phase III Data And FDA BLA Filing
28-03-2026
yahoo.com
Summit Therapeutics (SMMT) Is Up 6.9% After Phase III Ivonescimab Data And FDA Filing - What's Changed
28-03-2026
yahoo.com
Why Is Ironwood (IRWD) Down 13.9% Since Last Earnings Report?
27-03-2026
yahoo.com
Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026
27-03-2026
yahoo.com
What Makes Summit Therapeutics (SMMT) One of the Best Large Caps Under $30
26-03-2026
yahoo.com
Summit Therapeutics (SMMT) Climbs 15.4% Ahead of Pipeline Q2 Updates
26-03-2026
yahoo.com
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now
25-03-2026
fool.com
Is Summit Therapeutics (SMMT) Pricing Reflect Long Term Value After Recent Share Price Swings
03-03-2026
yahoo.com
Summit Therapeutics (SMMT) Ends 2025 With Strong Cash Reserves and Increased Clinical Investment
03-03-2026
yahoo.com
What is the current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The current price of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is $25.16.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) absolute price change since previous trading day?
The absolute price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is $0.74.
SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) percentage price change since previous trading day?
The percentage price change of SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) since the previous trading day is 3.0303%.
What is the most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent average sentiment score for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)?
The most recent sentiment for SUMMIT THERAPEUTICS INC (SMMT:NASDAQ) is .
SEC-8K** Filing Available For SUMMIT THERAPEUTICS INC (SMMT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.